Literature DB >> 170308

Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus.

N E Cremer, N J Schmidt, F Jensen, M Hoffman, L S Oshiro, E H Lennette.   

Abstract

Antibody titers to cytomegalovirus were determined in 204 single-serum specimens and in 138 serum pairs, utilizing as antigen extracts of infected cells prepared by either freezing and thawing cells (FT antigen) or extracting them with a glycine buffer (GE antigen). With the serum pairs, 40% of the early sera and 44% of the late sera showed a fourfold or higher antibody titer with the GE antigen compared with those with the FT antigen, whereas 39% of the single sera had a fourfold or higher titer with the GE antigen. Sucrose density gradient centrifugation of the two antigen preparations indicated that the GE antigen contained two peaks of complement-fixing activity, one at a density of 1.18 to 1.22 g/cm3 and one at 1.06 to 1.10 g/cm3. The FT antigen had only one discernible peak of complement-fixing activity at 1.04 to 1.10 g/cm3. On electron microscopy, the more dense peak contained mainly nucleocapsids with some dense bodies and occasional enveloped virions, and the lighter peak was composed of amorphous material. Antibody titers obtained with the crude GE antigen and the more dense peak (designated viral antigen) were in agreement, whereas titers with the FT antigen agreed with those obtained with the lighter peak (soluble antigen). The antibody detected with both antigens was mainly immunoglobulin G.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170308      PMCID: PMC275052          DOI: 10.1128/jcm.1.3.262-267.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.

Authors:  U Krech; M Jung; W Sonnabend
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1971-06

2.  Comparison of human cytomegalovirus obtained by glycine extraction and by sonic disruption of infected cells.

Authors:  F Probstmeyer; M Benyesh-Melnick; R M McCombs
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

3.  Congenital cytomegalovirus infection: laboratory methods of detection.

Authors:  J B Hanshaw
Journal:  J Pediatr       Date:  1969-12       Impact factor: 4.406

4.  Nonviral microbodies with viral antigenicity produced in cytomegalovirus-infected cells.

Authors:  J E Craighead; R E Kanich; J D Almeida
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

5.  Propagation and purification of high-titer human cytomegalovirus.

Authors:  R W Chambers; J A Rose; A S Rabson; H E Bond; W T Hall
Journal:  Appl Microbiol       Date:  1971-11
  5 in total
  16 in total

1.  Cell-mediated immunity to cytomegalovirus in immunocompromised patients: effect of radiation or chemotherapy.

Authors:  Y Agatsuma; P Fitzpatrick; A Kaul; R Kaul; R Kohli; A V Paves; P L Ogra
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody.

Authors:  J C Booth; G Hannington; T A Aziz; H Stern
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

3.  A comparison of complement fixation, indirect immunofluorescence for viral late antigens, and anti-complement immunofluorescence tests for the detection of cytomegalovirus specific serum antibodies.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

4.  Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection.

Authors:  N E Cremer; M Hoffman; E H Lennette
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

5.  Retrospective investigation of transfusion-related non-A, non-B viral hepatitis associated with M2 antigen.

Authors:  S Field; R Hopkins; J Davidson; E Coutts; N D Finlayson; O E Eade; S J Nixon; A C Parker
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

6.  Antisera to human cytomegalovirus produced in hamsters: reactivity in radioimmunoassay and other antibody assay systems.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

7.  Comparative activity of immunofluorescent antibody and complement-fixing antibody in cytomegalovirus infection.

Authors:  R F Betts; S D George; R B Rundell; R B Freeman; R G Douglas
Journal:  J Clin Microbiol       Date:  1976-08       Impact factor: 5.948

8.  Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

9.  Anti-complement immunofluorescence test for antibodies to human cytomegalovirus.

Authors:  J D Kettering; N J Schmidt; D Gallo; E H Lennette
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

10.  Role of rheumatoid factor in complement fixation and indirect hemagglutination tests for immunoglobulin M antibody to cytomegalovirus.

Authors:  N E Cremer; M Hoffman; E H Lennette
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.